This study will assess the cost and feasibility of two strategies of enhanced Mass Drug
Administration (MDA) of Zithromax to treat trachoma in the Republic of South Sudan. The
secondary objectives of this study are to measure trachoma infection outcomes during the
12-month follow-up period among children up to 9 years of age.